| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $45.7M | -50.7% |
| Cost of Revenue | $14.2M | — |
| R&D Expense | $20.7M | -22.8% |
| SG&A Expense | $53.3M | -8.8% |
| Operating Income | -$81.3M | +7.9% |
| Pre-tax Income | -$112.0M | -11.7% |
| Income Tax | -$228K | +94.1% |
| Net Income | -$111.7M | -198.9% |
| EPS (Basic) | -$1.76 | -79.6% |
| EPS (Diluted) | -$1.76 | -79.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.4M | +62.2% |
| Accounts Receivable | $36.8M | +14.9% |
| Current Assets | $73.9M | +24.4% |
| Total Assets | $182.3M | -8.0% |
| Current Liabilities | $103.8M | +70.3% |
| Total Liabilities | $114.2M | -38.2% |
| Stockholders' Equity | $68.1M | +406.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.2M | -115.2% |
| Capital Expenditures | $5.0M | -18.4% |
| Investing Cash Flow | -$5.0M | -209.6% |
| Financing Cash Flow | $69.4M | +287.3% |
| Free Cash Flow | -$58.2M | -88.8% |